# Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome

> **NCT00412802** · PHASE4 · COMPLETED · sponsor: **French Cardiology Society** · enrollment: 67 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Renal Failure

## Interventions

- **DRUG:** dose adaptation of Enoxaparin
- **DRUG:** normal injection of Enoxaparine

## Key facts

- **NCT ID:** NCT00412802
- **Lead sponsor:** French Cardiology Society
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2011-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412802, "Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00412802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*